These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7698287)

  • 21. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
    Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE
    J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta complexes with thrombospondin.
    Murphy-Ullrich JE; Schultz-Cherry S; Höök M
    Mol Biol Cell; 1992 Feb; 3(2):181-8. PubMed ID: 1550960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro.
    Grzesik WJ; Robey PG
    J Bone Miner Res; 1994 Apr; 9(4):487-96. PubMed ID: 7518179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.
    Long MW; Robinson JA; Ashcraft EA; Mann KG
    J Clin Invest; 1995 Feb; 95(2):881-7. PubMed ID: 7860771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta and basement membrane matrigel stimulate the chondrogenic phenotype in osteoblastic cells derived from fetal rat calvaria.
    Basic N; Basic V; Bulic K; Grgic M; Kleinman HK; Luyten FP; Vukicevic S
    J Bone Miner Res; 1996 Mar; 11(3):384-91. PubMed ID: 8852949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro human osteoblast and extracellular matrix changes after transforming growth factor beta 1 treatment.
    Stabellini G; Vertemati M; Locci P; Calvitti M; Minola E; Calastrini C; Pellati A; Carinci F; Marinucci L; Lilli C; Baroni T
    Pathology; 2005 Oct; 37(5):347-54. PubMed ID: 16194844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
    Daniel C; Wagner A; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
    Schultz-Cherry S; Murphy-Ullrich JE
    J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.
    Yokose S; Ishizuya T; Ikeda T; Nakamura T; Tsurukami H; Kawasaki K; Suda T; Yoshiki S; Yamaguchi A
    Endocrinology; 1996 Feb; 137(2):469-78. PubMed ID: 8593791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures.
    Méndez-Dávila C; García-Moreno C; Turbì C; de la Piedra C
    J Endocrinol Invest; 2004 Nov; 27(10):904-12. PubMed ID: 15762036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation.
    Graham CH; Lysiak JJ; McCrae KR; Lala PK
    Biol Reprod; 1992 Apr; 46(4):561-72. PubMed ID: 1374270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone.
    Oursler MJ; Cortese C; Keeting P; Anderson MA; Bonde SK; Riggs BL; Spelsberg TC
    Endocrinology; 1991 Dec; 129(6):3313-20. PubMed ID: 1954907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture.
    Talley-Ronsholdt DJ; Lajiness E; Nagodawithana K
    In Vitro Cell Dev Biol Anim; 1995 Apr; 31(4):274-82. PubMed ID: 7795846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cell accumulation and collagen processing by keratocytes cultured under agarose and in media containing IGF-I, TGF-β or PDGF.
    Etheredge L; Kane BP; Valkov N; Adams S; Birk DE; Hassell JR
    Matrix Biol; 2010 Jul; 29(6):519-24. PubMed ID: 20580823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of normal female human osteoblasts (NHOst) to 17beta-estradiol is modulated by implant surface morphology.
    Lohmann CH; Tandy EM; Sylvia VL; Hell-Vocke AK; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Biomed Mater Res; 2002 Nov; 62(2):204-13. PubMed ID: 12209940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
    Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
    J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro.
    Canfield AE; Sutton AB; Hoyland JA; Schor AM
    J Cell Sci; 1996 Feb; 109 ( Pt 2)():343-53. PubMed ID: 8838658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 beta-estradiol.
    Mathieu E; Merregaert J
    J Bone Miner Res; 1994 Feb; 9(2):183-92. PubMed ID: 8140931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.